Quarterly report · Q1
2112.TEDINET S100OV90
Period2022-04-01 → 2022-06-30
Filed2022-08-05
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥6.9bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥25.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥6.3bn | 2021-04-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥171m | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥245m | 2021-04-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥296m | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥906m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥366m | 2021-04-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥296m | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥366m | 2021-04-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥224m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥609m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥276m | 2021-04-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥224m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥276m | 2021-04-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥25.9bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥26.1bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥26.2bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥15.5bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥15.7bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥10.4bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥10.4bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥10.1bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.5bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.5bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥8.24 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.43 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.16 | 2021-04-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 40.3% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.7% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.4% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2022-04-01 → 2022-06-30 | ¥33m |
| Otherother segments | revenue external | 2022-04-01 → 2022-06-30 | ¥29m |
| Otherother segments | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥4m |
| Otherother segments | segment profit | 2022-04-01 → 2022-06-30 | ¥16m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥43m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥43m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥307m |
| jpcrp040300-q1r_E00361-000Biotechnologyreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥491m |
| jpcrp040300-q1r_E00361-000Biotechnologyreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥458m |
| jpcrp040300-q1r_E00361-000Biotechnologyreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥32m |
| jpcrp040300-q1r_E00361-000Biotechnologyreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥137m |
| jpcrp040300-q1r_E00361-000Sugarreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥6.4bn |
| jpcrp040300-q1r_E00361-000Sugarreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥6.4bn |
| jpcrp040300-q1r_E00361-000Sugarreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥6m |
| jpcrp040300-q1r_E00361-000Sugarreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥325m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥6.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥6.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥43m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥479m |
| Otherother segments | revenue | 2021-04-01 → 2021-06-30 | ¥33m |
| Otherother segments | revenue external | 2021-04-01 → 2021-06-30 | ¥29m |
| Otherother segments | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥4m |
| Otherother segments | segment profit | 2021-04-01 → 2021-06-30 | ¥15m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-06-30 | −¥38m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-06-30 | −¥38m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-06-30 | −¥311m |
| jpcrp040300-q1r_E00361-000Biotechnologyreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥463m |
| jpcrp040300-q1r_E00361-000Biotechnologyreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥435m |
| jpcrp040300-q1r_E00361-000Biotechnologyreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥27m |
| jpcrp040300-q1r_E00361-000Biotechnologyreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥127m |
| jpcrp040300-q1r_E00361-000Sugarreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥5.8bn |
| jpcrp040300-q1r_E00361-000Sugarreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥5.8bn |
| jpcrp040300-q1r_E00361-000Sugarreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥6m |
| jpcrp040300-q1r_E00361-000Sugarreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥413m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-06-30 | ¥6.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-06-30 | ¥6.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥38m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-06-30 | ¥557m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 354
| Item | Context | Value | Unit |
|---|---|---|---|
| Profit loss | Prior1YTDDuration | 276000000 | JPY |
| Profit loss | CurrentYTDDuration | 224000000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 276000000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 224000000 | JPY |
| Profit loss | Prior1YTDDuration | 276000000 | JPY |
| Profit loss | CurrentYTDDuration | 224000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | -10000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | -24000000 | JPY |
| Deferred gains or losses on hedges net of tax oci | Prior1YTDDuration | -0 | JPY |
| Deferred gains or losses on hedges net of tax oci | CurrentYTDDuration | 0 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | 1000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | -0 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | Prior1YTDDuration | -0 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | CurrentYTDDuration | -0 | JPY |
| Other comprehensive income | Prior1YTDDuration | -9000000 | JPY |
| Other comprehensive income | CurrentYTDDuration | -25000000 | JPY |
| Comprehensive income | Prior1YTDDuration | 266000000 | JPY |
| Comprehensive income | CurrentYTDDuration | 198000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 266000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 198000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E00361-000SugarReportableSegmentsMember | 5790000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E00361-000BiotechnologyReportableSegmentsMember | 435000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_OtherReportableSegmentsMember | 29000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 6255000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 6255000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E00361-000SugarReportableSegmentsMember | 6000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E00361-000BiotechnologyReportableSegmentsMember | 27000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_OtherReportableSegmentsMember | 4000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 38000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -38000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00361-000SugarReportableSegmentsMember | 5797000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00361-000BiotechnologyReportableSegmentsMember | 463000000 | JPY |
| Net sales | Prior1YTDDuration_OtherReportableSegmentsMember | 33000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 6294000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -38000000 | JPY |
| Net sales | Prior1YTDDuration | 6255000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00361-000SugarReportableSegmentsMember | 413000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00361-000BiotechnologyReportableSegmentsMember | 127000000 | JPY |
| Operating income | Prior1YTDDuration_OtherReportableSegmentsMember | 15000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 557000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -311000000 | JPY |
| Operating income | Prior1YTDDuration | 245000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00361-000SugarReportableSegmentsMember | 6391000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00361-000BiotechnologyReportableSegmentsMember | 458000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OtherReportableSegmentsMember | 29000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 6879000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 6879000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |